The Effect of Hydroxytyrosol in Type II Epithelial-Mesenchymal Transition in Human Skin Wound Healing

Skin wound healing is a multiphase physiological process that involves the activation of numerous types of cells and is characterized by four phases, namely haemostasis, inflammatory, proliferative, and remodeling. However, on some occasions this healing becomes pathological, resulting in fibrosis. Epithelial mesenchymal transition (EMT) is an important process in which epithelial cells acquire mesenchymal fibroblast-like characteristics. Hydroxytyrosol (HT) is a phenolic compound extracted from olive oil and has been proven to have several health benefits. The aim of this study was to determine the effect of HT in type II EMT in human skin wound healing via cell viability, proliferation, migration, and proteins expression. Human dermal fibroblasts (HDF) isolated from skin samples were cultured in different concentrations of HT and EMT model, induced by adding 5 ng/mL of transforming growth factor-beta (TGF-β) to the cells. HT concentrations were determined via 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cells’ migrations were evaluated using scratch and transwell migration assay. Protein expressions were evaluated via immunocytochemistry. The result showed that HT at 0.2% and 0.4% significantly increased the proliferation rate of HDF (p < 0.05) compared to control. Scratch assay after 24 h showed increased cell migration in cells treated with 0.4% HT (p < 0.05) compared to the other groups. After 48 h, both concentrations of HT showed increased cell migration (p < 0.05) compared to the TGF-β group. Transwell migration revealed that HT enhanced the migration capacity of cells significantly (p < 0.05) as compared to TGF-β and the control group. In addition, HT supplemented cells upregulate the expression of epithelial marker E-cadherin while downregulating the expression of mesenchymal marker vimentin in comparison to TGF-β group and control group. This study showed that HT has the ability to inhibit EMT, which has potential in the inhibition of fibrosis and persistent inflammation related to skin wound healing.

[1]  H. Hasmad,et al.  Electrospun Fiber-Coated Human Amniotic Membrane: A Potential Angioinductive Scaffold for Ischemic Tissue Repair , 2022, International journal of molecular sciences.

[2]  S. Pierdomenico,et al.  Epithelial-Mesenchymal Transition (EMT): The Type-2 EMT in Wound Healing, Tissue Regeneration and Organ Fibrosis , 2021, Cells.

[3]  Haliza Katas,et al.  Molecular Action of Hydroxytyrosol in Wound Healing: An In Vitro Evidence-Based Review , 2020, Biomolecules.

[4]  B. Conti,et al.  Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration , 2020, Pharmaceutics.

[5]  C. Vecchione,et al.  3-Hydroxytyrosol Promotes Angiogenesis In Vitro by Stimulating Endothelial Cell Migration , 2020, International journal of molecular sciences.

[6]  C. Ventura,et al.  Fibroblast Proliferation and Migration in Wound Healing by Phytochemicals: Evidence for a Novel Synergic Outcome , 2020, International journal of medical sciences.

[7]  S. Fakurazi,et al.  In Vitro Wound Healing Potential of Flavonoid C-Glycosides from Oil Palm (Elaeis guineensis Jacq.) Leaves on 3T3 Fibroblast Cells , 2020, Antioxidants.

[8]  T. Beccari,et al.  Hydroxytyrosol: a natural compound with promising pharmacological activities. , 2019, Journal of biotechnology.

[9]  V. Cardile,et al.  Hydroxytyrosol from olive fruits prevents blue‐light‐induced damage in human keratinocytes and fibroblasts , 2018, Journal of cellular physiology.

[10]  S. Jeon,et al.  Anti-inflammatory and anti-aging effects of hydroxytyrosol on human dermal fibroblasts (HDFs) , 2018, Biomedical Dermatology.

[11]  A. Saim,et al.  The potential of Olea europaea extracts to prevent TGFβ1-induced epithelial to mesenchymal transition in human nasal respiratory epithelial cells , 2018, BMC Complementary and Alternative Medicine.

[12]  Z. Bouallagui,et al.  Oleuropein and hydroxytyrosol rich extracts from olive leaves attenuate liver injury and lipid metabolism disturbance in bisphenol A-treated rats. , 2018, Food & function.

[13]  D. Haensel,et al.  Epithelial‐to‐mesenchymal transition in cutaneous wound healing: Where we are and where we are heading , 2018, Developmental dynamics : an official publication of the American Association of Anatomists.

[14]  G. Ros,et al.  Hydroxytyrosol: Health Benefits and Use as Functional Ingredient in Meat , 2018, Medicines.

[15]  X. Fu,et al.  Hydroxytyrosol contributes to cell proliferation and inhibits apoptosis in pulsed electromagnetic fields treated human umbilical vein endothelial cells in vitro , 2017, Molecular medicine reports.

[16]  Jer-Tsong Hsieh,et al.  The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression , 2017, International journal of molecular sciences.

[17]  J. Law,et al.  Role of plasma-derived fibrin on keratinocyte and fibroblast wound healing , 2017, Cell and Tissue Banking.

[18]  S. Jana,et al.  Protective effects of tetrahydrocurcumin (THC) on fibroblast and melanoma cell lines in vitro: it’s implication for wound healing , 2017, Journal of Food Science and Technology.

[19]  S. López,et al.  Effect of metabolites of hydroxytyrosol on protection against oxidative stress and inflammation in human endothelial cells , 2017 .

[20]  M. Tomic-Canic,et al.  Epithelial-mesenchymal transition in tissue repair and fibrosis , 2016, Cell and Tissue Research.

[21]  M. Ståhle,et al.  Transition from inflammation to proliferation: a critical step during wound healing , 2016, Cellular and Molecular Life Sciences.

[22]  A. Pastor,et al.  Metabolic disposition and biological significance of simple phenols of dietary origin: hydroxytyrosol and tyrosol , 2016, Drug metabolism reviews.

[23]  E. Caterson,et al.  Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound. , 2014, Advances in wound care.

[24]  S. Verma,et al.  Endothelial cell control of thrombosis , 2015, BMC Cardiovascular Disorders.

[25]  D. Corella,et al.  Mediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial. , 2015, JAMA internal medicine.

[26]  C. Jackson,et al.  Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring. , 2015, Advances in wound care.

[27]  Muhammad Ali Hashmi,et al.  Traditional Uses, Phytochemistry, and Pharmacology of Olea europaea (Olive) , 2015, Evidence-based complementary and alternative medicine : eCAM.

[28]  O. Stojadinović,et al.  Clinical application of growth factors and cytokines in wound healing , 2014, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[29]  B. Romana-Souza,et al.  Supplementation with olive oil, but not fish oil, improves cutaneous wound healing in stressed mice , 2014, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[30]  Rakesh Kumar,et al.  Nuclear Signaling Pathways and Targeting Transcription in Cancer , 2014, Cancer Drug Discovery and Development.

[31]  Jean Paul Thiery,et al.  Early events in cell adhesion and polarity during epithelial-mesenchymal transition , 2012, Journal of Cell Science.

[32]  K. Chua,et al.  Correction: Shelf-Life Evaluation of Bilayered Human Skin Equivalent, MyDerm™ , 2012, PLoS ONE.

[33]  K. Chua,et al.  Shelf-Life Evaluation of Bilayered Human Skin Equivalent, MyDerm™ , 2012, PloS one.

[34]  B. S. Aminuddin,et al.  Expansion of human articular chondrocytes and formation of tissue-engineered cartilage: a step towards exploring a potential use of matrix-induced cell therapy. , 2010, Tissue & cell.

[35]  K. Khosrotehrani,et al.  Skin wound healing modulation by macrophages. , 2010, International journal of clinical and experimental pathology.

[36]  Russell Keast,et al.  Biological Activities of Phenolic Compounds Present in Virgin Olive Oil , 2010, International journal of molecular sciences.

[37]  Tomaz Velnar,et al.  The Wound Healing Process: An Overview of the Cellular and Molecular Mechanisms , 2009, The Journal of international medical research.

[38]  M. Nieto,et al.  Inflammation and EMT: an alliance towards organ fibrosis and cancer progression , 2009, EMBO molecular medicine.

[39]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[40]  E. Fearon,et al.  The transcription factor snail represses Crumbs3 expression and disrupts apico-basal polarity complexes , 2008, Oncogene.

[41]  Raymond B. Runyan,et al.  TGFβ‐mediated RhoA expression is necessary for epithelial‐mesenchymal transition in the embryonic chick heart , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[42]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[43]  R. Mason,et al.  TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) , 2005, Respiratory research.

[44]  C. Heldin,et al.  TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. , 2005, Molecular biology of the cell.

[45]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.